-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Eo39H+PnymPHvRnbTWGRU4hewNZ/Y4U1x5+OrWEujiEJY+ZoLs72zep43k8ByEju vUDiIebeSmeDYkdoqfNykw== 0000891618-99-004850.txt : 19991104 0000891618-99-004850.hdr.sgml : 19991104 ACCESSION NUMBER: 0000891618-99-004850 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19991102 ITEM INFORMATION: FILED AS OF DATE: 19991103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-09813 FILM NUMBER: 99740216 BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 4152251000 MAIL ADDRESS: STREET 1: 460 POINT SAN BRUNO BLVD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 FORM 8-K 1 ================================================================================ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 --------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (date of earliest event reported): November 2, 1999 Genentech, Inc. (Exact name of registrant as specified in its charter) Delaware 94-2345624 (State of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.
--------------- 1 DNA Way South San Francisco, California 94080-4990 (Address of Principal Executive Offices) (Zip Code) --------------- Genentech, Inc. 1 DNA Way South San Francisco, California 94080-4990 (Address of Principal Executive Offices) (650) 225-1000 (Registrant's Telephone Number, Including Area Code) 2 INFORMATION TO BE INCLUDED IN THE REPORT Item 5: Other Events Genentech, Inc. has effected a 2-for-1 stock split in the form of a stock dividend. The record date of such stock split was October 29, 1999, meaning that shareholders of record of Genentech common stock at the close of business on that date became entitled to receive one additional share of Genentech common stock for each share held. The additional shares were distributed on November 2, 1999. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GENENTECH, INC. Date: November 3, 1999. By: /s/ Arthur D. Levinson -------------------------------------- Name: Arthur D. Levinson, Ph.D. Title: Chairman and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----